After finishing at $1.22 in the prior trading day, Affimed N.V. (NASDAQ: AFMD) closed at $1.16, down -4.92%. In other words, the price has decreased by -$0.0600 from its previous closing price. On the day, 2358292 shares were traded. AFMD stock price reached its highest trading level at $1.2500 during the session, while it also had its lowest trading level at $1.1600.
Our goal is to gain a better understanding of AFMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.60 and its Current Ratio is at 5.60. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 12, 2022, initiated with a Buy rating and assigned the stock a target price of $6.
On October 10, 2022, Stifel Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $9 to $2.
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.70 while its Price-to-Book (P/B) ratio in mrq is 0.89.
Stock Price History:
Over the past 52 weeks, AFMD has reached a high of $5.10, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is 1.6062, while the 200-Day Moving Average is calculated to be 2.5315.
The stock has traded on average 2.15M shares per day over the past 3-months and 2.22M shares per day over the last 10 days, according to various share statistics. A total of 149.34M shares are outstanding, with a floating share count of 137.53M. Insiders hold about 3.40% of the company’s shares, while institutions hold 66.20% stake in the company. Shares short for AFMD as of Oct 13, 2022 were 3.79M with a Short Ratio of 4.01M, compared to 3.95M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.54% and a Short% of Float of 2.62%.
Its stock is currently analyzed by 8 different market analysts. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.25, while EPS last year was -$0.16. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.14 and low estimates of -$0.28.
Analysts are recommending an EPS of between -$0.56 and -$0.86 for the fiscal current year, implying an average EPS of -$0.67. EPS for the following year is -$0.82, with 8 analysts recommending between -$0.63 and -$1.08.
7 analysts predict $7.44M in revenue for the current quarter. It ranges from a high estimate of $8.86M to a low estimate of $5.55M. As of the current estimate, Affimed N.V.’s year-ago sales were $9.46M, an estimated decrease of -21.40% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $7.31M, a decrease of -34.10% less than the figure of -$21.40% in the same quarter last year. There is a high estimate of $9.18M for the next quarter, whereas the lowest estimate is $5.28M.
A total of 7 analysts have provided revenue estimates for AFMD’s current fiscal year. The highest revenue estimate was $35.17M, while the lowest revenue estimate was $26.54M, resulting in an average revenue estimate of $30.51M. In the same quarter a year ago, actual revenue was $43.32M, down -29.60% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $33.41M in the next fiscal year. The high estimate is $83.97M and the low estimate is $2.02M. The average revenue growth estimate for next year is up 9.50% from the average revenue estimate for this year.